Refers to a Solid Pharmaceutical composition comprising: a) a benzimidazole Compound of formula (i) wherein R1 is a group monociclico Heterocyclic containing nitrogen and a hydrogen Atom desprotonable, R2 is optionally Esterified carboxyl,R3 is optionally substituted Lower alkyl and Compounds being Preferred: 1 - (ciclohexiloxicarboniloxi) - ethoxy Ethyl 2 - [1 - [2 - (1h-tetrazol-5-yl) biphenyl - 4-yl] methyl] benzimidazole - 7 - carboxylate, 2-ethoxy - [1 - (2 - 1h-tetrazol-5-yl) biphenyl - 4-yl] methyl] - 1H benzimidazole - 7 - carboxylic acid 2-ethoxy - [1 - (2 - 4,5-dihydro - (5 - oxo - 1.2.Oxadiazoles - 4 - 3 - il) biphenyl - 4-yl] methyl] - 1H benzimidazole - 7 - carboxylic acid (b) a Sugar alcohol such as sorbitol or mannitol and Erythritol (c) as a Calcium antagonist amlodipine, azelnidipina, aranidipina, among others and (d) polyethylene glycol of Molecular Weight from 1000 to 10000.Said composition has a better stability of the benzimidazole derivative is useful in the treatment of hypertensionSE REFIERE A UNA COMPOSICION FARMACEUTICA SOLIDA QUE COMPRENDE: A) UN COMPUESTO BENZIMIDAZOL DE FORMULA (I) DONDE R1 ES UN GRUPO HETEROCICLICO QUE CONTIENE NITROGENO MONOCICLICO Y UN ATOMO DE HIDROGENO DESPROTONABLE, R2 ES CARBOXILO OPCIONALMENTE ESTERIFICADO, Y R3 ES ALQUILO INFERIOR OPCIONALMENTE SUSTITUIDO SIENDO COMPUESTOS PREFERIDOS: 1-(CICLOHEXILOXICARBONILOXI)ETIL 2-ETOXI-1-[[2-(1H-TETRAZOL-5-IL)BIFENIL-4-IL]METIL]BENZIMIDAZOL-7-CARBOXILATO, 2-ETOXI-1-[[2-(1H-TETRAZOL-5-IL)BIFENIL-4-IL]METIL]-1H-BENZIMIDAZOL-7-CARBOXILICO, ACIDO 2-ETOXI-1-[[2-(4,5-DIHIDRO-5-OXO-1,2,4-OXADIAZOL-3-IL)BIFENIL-4-IL]METIL]-1H-BENZIMIDAZOL-7-CARBOXILICO B) UN ALCOHOL DE AZUCAR TAL COMO MANITOL, SORBITOL O ERITRITOL C) UN ANTAGONISTA DE CALCIO TAL COMO AMLODIPINA, AZELNIDIPINA, ARANIDIPINA, ENTRE OTROS Y D) POLIETILENO GLICOL DE PESO MOLECULAR DE 1.000 A 10.000. DICHA COMPOSICION PRESENTA UNA MEJOR ESTABILIDAD DEL DERIVADO BENZIMIDAZOL SIENDO UTIL EN EL TRATAMIENTO DE LA HIPERTENSIO
